BATS BZX Real-Time Price
As of 1:55pm ET
| +0.38 / +0.34%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 114.00, with a high estimate of 132.00 and a low estimate of 85.00. The median estimate represents a +1.15% increase from the last price of 112.70.
The current consensus among 9 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.